Align Technology Completes Acquisition of Cubicure, a Pioneer of Direct 3D Printing Solutions for Polymer Additive Manufacturing
2024年1月4日 - 6:02AM
ビジネスワイヤ(英語)
Align continues to innovate and invest in
technologies that enable the next generation of direct 3D printed
products, thus helping us create more sustainable and efficient
solutions.
Align Technology, Inc. (Align) (Nasdaq: ALGN) a leading global
medical device company that designs, manufactures, and sells the
Invisalign® system of clear aligners, iTero™ intraoral scanners,
and exocad™ CAD/CAM software for digital orthodontics and
restorative dentistry, today announced that it has completed the
acquisition of privately-held Cubicure GmbH, a pioneer in direct 3D
printing solutions for polymer additive manufacturing that
develops, produces, and distributes innovative materials,
equipment, and processes for novel 3D printing solutions.
The acquisition of Cubicure will support and scale Align’s
strategic innovation roadmap and strengthen the Align Digital
Platform™. Cubicure will also extend and scale Align’s printing,
materials, and manufacturing capabilities for our 3D printed
product portfolio which now includes the Invisalign® Palatal
Expander system, Align’s first direct 3D printed orthodontic device
and a safe, comfortable, and clinically effective* alternative to
traditional palatal expanders. Cubicure’s patented Hot Lithography
technology uses a special heating and coating mechanism that
enables the processing of highly viscous resins to produce
particularly tough and temperature-resistant polymers. This high
precision 3D printing process facilitates the unprecedented
additive manufacturing of resilient components with an astonishing
first of its kind material quality performance.
Commenting on today’s announcement, Joe Hogan, Align Technology
president and CEO said, “The acquisition of Cubicure brings a
talented team and unique cutting-edge technology into Align and
will enable us to scale our 3D printing operations to eventually
direct print millions of custom appliances per day. Direct 3D
printing enables Align to create 3D printed solutions without the
added step of first creating a mold, making 3D printing more
sustainable and efficient. I am excited to take this important step
in our relationship with Cubicure, which began several years ago as
a joint development program.”
“Align has invested billions of dollars on innovation over the
past 27 years, including next-generation 3D printing technologies
to process high-performance polymers,” said Srini Kaza, Align
senior vice president, product research & development. “We’ve
been working with Cubicure for years and I am thrilled that they
are now officially employees of Align and members of our R&D
organization. We're at the beginning of this next wave of direct 3D
printing additive manufacturing and I believe we're poised to
transform the orthodontic industry again with our unprecedented
ability to direct print devices.”
The acquisition closed on January 2, 2024, for approximately €79
million subject to final closing adjustments and adjustments for
Align’s existing ownership of capital stock of Cubicure.
*Based on a survey in August 2023 in Canada of 10 Invisalign
trained orthodontists who participated in the Invisalign Palatal
Expander System Technical Design Assessment and have treated at
least 1 patient age 6-11 years with IPE. Data on file at Align
Technology, Inc. as of October 30, 2023.
About Align Technology,
Inc.
Align Technology designs and manufactures the Invisalign®
system, the most advanced clear aligner system in the world, iTero™
intraoral scanners and services, and exocad™ CAD/CAM software.
These technology building blocks enable enhanced digital
orthodontic and restorative workflows to improve patient outcomes
and practice efficiencies for approximately 252 thousand doctor
customers and are key to accessing Align’s 600 million consumer
market opportunity worldwide. Over the past 26 years, Align has
helped doctors treat over 16.4 million patients with the Invisalign
system and is driving the evolution in digital dentistry through
the Align Digital Platform™, our integrated suite of unique,
proprietary technologies and services delivered as a seamless,
end-to-end solution for patients and consumers, orthodontists and
GP dentists, and lab/partners. Visit www.aligntech.com for more
information.
For additional information about the Invisalign system or to
find an Invisalign doctor in your area, please visit
www.invisalign.com. For additional information about the iTero
digital scanning system, please visit www.itero.com. For additional
information about exocad dental CAD/CAM offerings and a list of
exocad reseller partners, please visit www.exocad.com.
Invisalign, iTero, exocad, Align, and Align Digital Platform are
trademarks of Align Technology, Inc.
Forward-Looking
Statements
This news release and other information publicly disseminated by
us, contains forward-looking statements, including statements of
beliefs and expectations regarding expected transaction benefits
and synergies as a result of the acquisition, our 3D printing
operations and products, and other matters discussed in this press
release that are not purely historical data. We do not assume any
obligation to update or revise any such forward-looking statements,
whether as the result of new developments or otherwise.
Forward-looking statements contained in this news release relating
to expectations about future events or results are based upon
information available to Align as of the date hereof. Readers are
cautioned that these forward-looking statements reflect our best
judgments based on currently known facts and circumstances and are
subject to risks, uncertainties, and assumptions that are difficult
to predict. As a result, actual results may differ materially and
adversely from those expressed in any forward-looking
statements.
Factors that might cause such a difference include, but are not
limited to:
- the ability to: (i) realize expected synergies or benefits in
connection with the transaction within the expected timeframes or
not at all and (ii) timely, cost-efficiently and effectively
integrate Cubicure’s business without adversely impacting
operations of either Align or Cubicure;
- the effect of the closing of the transaction on (i) Align’s and
Cubicure’s relationships with their respective customers,
suppliers, strategic partners and competitors and their operating
results and businesses generally (including the diversion of
management time on transaction-related issues) and (ii) the ability
to retain and hire key personnel;
- uncertainties associated with any aspect of the transaction,
including those related to (i) fluctuations in foreign exchange
rates and transaction costs, and (ii) litigation in connection with
the transaction itself or ongoing matters acquired from
Cubicure;
- the potential that our due diligence did not uncover risks and
potential liabilities associated with Cubicure;
- risks relating to financial reporting including those resulting
from the implementation of new or changed accounting policies and
practices as well as associated system implementation in the
context of the transaction as well as our ability to forecast
financial results;
- the potential impact of the transaction on our future tax rate
and payments based on the consolidation of the global group and our
ability to integrate foreign operations; and
- the potential negative effects of the announcement of the
transaction on the market price of Align’s common stock
The foregoing and other risks are detailed from time to time in
our periodic reports filed with the Securities and Exchange
Commission, including, but not limited to, our Annual Report on
Form 10-K for the year ended December 31, 2022, which was filed
with the Securities and Exchange Commission ("SEC") on February 27,
2023, and our latest Quarterly Report on Form 10-Q for the quarter
ended September 30, 2023, which was filed with the SEC on November
3, 2023. Align undertakes no obligation to revise or update
publicly any forward-looking statements for any reason.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240103882681/en/
Align Technology Madelyn Valente
(909) 833-5839 mvalente@aligntech.com
Zeno Group Sarah Johnson (828)
551-4201 sarah.johnson@zenogroup.com
Align Technology (NASDAQ:ALGN)
過去 株価チャート
から 11 2024 まで 12 2024
Align Technology (NASDAQ:ALGN)
過去 株価チャート
から 12 2023 まで 12 2024